Research shows the microbiome of atopic skin is less diverse than healthy skin1
The skin microbiome is a habitat of billions of beneficial and harmful bacteria.2


Healthy skin has a balanced microbiome and preserved skin barrier.


Atopic skin has an unbalanced microbiome and an altered skin barrier, making skin vulnerable to irritants and allergens which can cause inflammation,

Improvements in the skin barrier correlate with improvements in microbial diversity3
  • The skin microbiome of lesional atopic skin differs from adjacent non-lesional skin1, 4-5
  • Worsening of AD and dysbiosis of the skin are strongly linked4
  • Enhancing the skin barrier in AD and improving bacterial diversity could potentially avoid flares3
Optimizing the skin barrier helps to balance the microbiome and improves itchy, dry skin6-9
Clinical Support
Improve the Balance in AD
New study results show regular use of AVEENO® Eczema Therapy Moisturizing Cream helps to balance the microbiome and improve itchy, dry skin6


Professional Column
Our Commitment to Understanding the Role of the Microbiome in Skin Health
Kimberly Capone, PhD

Johnson & Johnson Consumer Inc. Consumer R&D community has been studying the microbiome for nearly a decade through both internal and external programs. We have uncovered significant advances in the infant and adult skin microbiome through our pioneering work. For the past 3 years, our focus has been on continuing to conduct fundamental research to better understand the healthy skin microbiome, while we concurrently look deeper into ways to correct microbiome imbalances present in a number of skin diseases.

Johnson & Johnson Consumer Inc. is committed to better understanding the role of the microbiome in skin health in a scientifically rigorous way in order to provide truly disruptive approaches to treating skin issues –particularly, inflammatory skin diseases. We are a leader in microbiome science and are working to translate its vast potential into therapies for patients and consumers around the world.